pretickt

DVA peers and competitors

DaVita Inc. · end-of-day data as of Oct 16, 2026

DaVita Inc.
DVA · $11.95B
$187.31-20.4%last 60 sessions · close Oct 16, 2026
$103.87$240.9652 weeks
Hold · 8 analystsPT $232.66 +24.2%
  • P/E vs own+7.5%
  • P/E vs sector-41.5%
  • Target upside+24.2%
  • Off 52w high-22.3%
  • Insiders-$36.51M
  • FCF yield+13.5%
  • Earnings in12d
  • Trendbullish
  • Sector▲ +16.0%
  • RSI58
  • MA20×50↑ in ~2d
  • Volume0.9x
  • Support-6.2%
  • Resistance+2.2%

DVA’s peers by industry and size include HCA Healthcare (HCA), Revvity (RVTY) and Solventum (SOLV). Among these 12 companies DVA ranks 6th by market cap ($11.95B); its P/E of 16.5 compares with a median of 25.2 for its peers.

Peers by industry and size

20D
1HCAHCA Healthcare, Inc.$458.84-2.1%-15.4%+2.1%15.4$99.34B
2RVTYRevvity, Inc.$152.64-1.3%-3.0%-18.2%72.7$17.03B
3SOLVSolventum Corporation$85.81-2.3%-7.2%+3.6%10.5$14.61B
4CRLCharles River Laboratories International, Inc.$300.15-2.0%-3.4%+3.1%—$14.46B
5BAXBaxter International Inc.$25.28-1.9%-10.8%-14.8%—$13.07B
6DVADaVita Inc.$187.31-1.0%-22.3%+24.2%16.5$11.95B
7TECHBio-Techne Corporation$72.57+0.1%-0.1%-7.0%62.6$11.38B
8COOThe Cooper Companies, Inc.$57.94+0.9%-31.3%+0.9%19.8$11.02B
9UHSUniversal Health Services, Inc.$185.10-1.2%-23.9%+11.1%7.6$10.91B
10ALGNAlign Technology, Inc.$147.31-1.4%-25.4%+35.1%25.6$10.46B
11PODDInsulet Corp.$141.10+1.7%-59.3%+32.3%26.4$9.79B
12HSICHenry Schein, Inc.$86.38-0.7%-4.9%+6.0%25.2$9.63B

Data as of Oct 16, 2026 close.